Pyrrole Compounds Inhibiting Bcl-2 Anti-Apoptotic Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective compounds to inhibit anti-apoptotic activity of the Bcl-2 family proteins, which are involved in various cancers and other pathologies, necessitating a therapeutic need for compounds that can regulate apoptosis.
Innovation Solution
Development of new pyrrole compounds with pro-apoptotic properties, specifically designed to inhibit the anti-apoptotic activity of Bcl-2 family proteins, which are prepared through a process involving a Heck reaction and peptide coupling, and can be used in pharmaceutical compositions for treating cancers and autoimmune diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used, then treatment of cancer and other pathologies is provided, but they lack effective compounds to inhibit anti-apoptotic activity of Bcl-2 family proteins
Solution Approach 1:
The patent employs parameter changes by modifying chemical structures of pyrrole compounds to achieve optimal inhibition of anti-apoptotic activity. Specific substitutions at positions R1-R6 and variations in molecular weight, lipophilicity, and binding affinity parameters enable the compounds to effectively target Bcl-2 family proteins while maintaining therapeutic reliability.
2Reliability
If new pyrrole compounds are developed to inhibit Bcl-2 family proteins, then pro-apoptotic properties are achieved, but complexity of compound structure increases
Solution Approach 1:
The pyrrole compounds are segmented into distinct functional modules: a core pyrrole ring system, substituent groups at positions R1-R6 that provide specific binding interactions, and pharmacophoric elements that confer pro-apoptotic activity. This segmentation allows systematic optimization of each module to achieve desired biological activity while managing structural complexity.
Solution Approach 2:
The pyrrole core structure serves multiple functions simultaneously: it provides the scaffold for Bcl-2 protein binding, enables diverse substituent attachment for optimizing pharmacological properties, and maintains structural flexibility for interacting with different Bcl-2 family members. This multi-functionality reduces the need for completely different molecular frameworks for various therapeutic indications.
3Reliability
If compounds are designed with specific substituent groups to enhance anti-apoptotic inhibition, then binding affinity is improved, but difficulty of synthesis increases
Solution Approach 1:
The synthesis strategy employs preliminary action by pre-forming key structural fragments and protecting groups before final assembly. Standardized building blocks with pre-installed functional groups (hydroxyl, amino, carboxyl) are prepared in advance, allowing modular assembly of complex substituted pyrroles through streamlined coupling reactions that reduce overall synthesis difficulty.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pyrrole compounds exhibit pro-apoptotic properties, reactivating the apoptotic process in cancerous cells, making them therapeutically relevant for treating chemoresistant cancers, autoimmune diseases, and other conditions associated with apoptosis dysregulation.
Implementation Method 1
a Heck reaction, in an aqueous or organic medium, in the presence of a palladium catalyst
Implementation Method 2
the aldehyde function of which compound of formula (IV) is oxidised to a carboxylic acid
Implementation Method 3
the ester function of which compound of formula (VII) is hydrolysed to yield the to corresponding carboxylic acid
Data Source
AI summary
Compounds of formula (I):wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, R5 and T are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.